Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

New Study Examines Cerebrovascular Events in Lupus Patients

  |  Issue: May 2019  |  

Linda Childers is a health writer located in the San Francisco Bay Area.

References

  1. Hanly JG, Li Q, Su L, et al. Cerebrovascular events in systemic lupus erythematosus: Results from an international inception cohort study. Arthritis Care Res (Hoboken). 2018 Oct;70(10):1478–1487.
  2. Barbhaiya M, Feldman CH, Guan H, et al. Racial/ethnic variation in stroke rates and risks among patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2019 Apr;48(5):840–846.
  3. Krishnan E. Stroke subtypes among young patients with systemic lupus erythematosus. Am J Med. 2005 Dec;118(12):1415.
  4. Yen EY, Singh RR. Brief report: Lupus an unrecognized leading cause of death in young females: A population-based study using nationwide death certificates, 2000–2015. Arthritis Rheum. 2018 Aug;70(8):1251–1255.

Related Articles

    Studies Examine Peripheral Nervous System Disease in Lupus Patients

    Although systemic lupus erythematosus (SLE) affects both the central nervous system (CNS) and peripheral nervous system (PNS), past research has primarily focused on how lupus affects the CNS. Now, an international, inception cohort study, “Peripheral Nervous System Disease in Systemic Lupus Erythematosus,” published in Arthritis & Rheumatology, has examined different types of PNS disease to…

    APS: What Rheumatologists Should Know about Hughes Syndrome

    The problem that dogs the work of all of those treating patients with antiphospholipid syndrome (APS) is the apparent lack of knowledge of the syndrome, both by the general public, as well as by swaths of the medical fraternity. Perhaps it was ever thus—a syndrome less than 40 years old could be described as new,…

    Case Report: Giant Cell Arteritis-Related Stroke

    Thromboembolic events are major contributors to the morbidity and mortality of patients with giant cell arteritis (GCA), but little is known about how GCA may increase the risk of ischemic strokes. GCA-related stroke is described as an ischemic cerebral infarct occurring within three to four weeks of GCA diagnosis and treatment. It occurs in 3–7%…